Azzad Asset Management Inc. ADV Has $1.45 Million Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Azzad Asset Management Inc. ADV lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.4% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 15,645 shares of the company’s stock after selling 543 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in U.S. Physical Therapy were worth $1,446,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in U.S. Physical Therapy by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after purchasing an additional 10,175 shares in the last quarter. Southernsun Asset Management LLC increased its holdings in U.S. Physical Therapy by 5.9% during the 4th quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock worth $44,634,000 after purchasing an additional 26,758 shares in the last quarter. Schroder Investment Management Group increased its holdings in U.S. Physical Therapy by 11.0% during the 4th quarter. Schroder Investment Management Group now owns 427,217 shares of the company’s stock worth $39,791,000 after purchasing an additional 42,281 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of U.S. Physical Therapy by 3.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 400,183 shares of the company’s stock valued at $37,274,000 after acquiring an additional 14,344 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of U.S. Physical Therapy by 3.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock valued at $14,515,000 after acquiring an additional 5,111 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $85.60 on Friday. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 69.59, a PEG ratio of 4.07 and a beta of 1.38. The business has a 50-day moving average of $91.08 and a 200-day moving average of $98.82. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a fifty-two week low of $78.08 and a fifty-two week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. During the same quarter last year, the business posted $0.76 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.55 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Friday, August 23rd will be paid a $0.44 dividend. The ex-dividend date is Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.06%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 143.09%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Barrington Research decreased their price objective on U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a report on Thursday, August 15th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and a consensus target price of $112.50.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.70% of the stock is currently owned by company insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.